Specific inhibitory effects of guanosine on breast cancer cell proliferation
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.06.069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Yusuke Takizawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, 10281 Komuro, Ina-machi, Kitaadachi-gun, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death. Drug therapy for breast cancer is currently selected based on the subtype classification; however, many anticancer drugs are highly cytotoxic. Since intracellular levels of GTP are elevated in many cancer cells that undergo a specific cell proliferation cycle, GTP has potential as a target for cancer therapy. The present study focused on nucleosides and nucleotides and examined intracellular GTP-dependent changes in cell proliferation rates in normal (MCF-12A) and cancer (MCF-7) breast cell lines. Decreased cell proliferation due to a reduction in intracellular GTP levels by mycophenolic acid (MPA), an inosine monophosphate dehydrogenase inhibitor, was observed in both cell lines. The inhibitory effects of MPA on cell proliferation were suppressed when it was applied in combination with Guanosine (Guo), a substrate for GTP salvage synthesis, while the single exposure to Guo suppressed the proliferation of MCF-7 cells only. Although the underlying mechanisms remain unclear, since the inhibitory effects of Guo on cell proliferation did not correlate with GTP or ATP intracellular levels or the GTP/ATP ratio, there may be another cause besides GTP metabolism. Guo inhibited the proliferation of MCF-7, a human breast cancer cell line, but not MCF-12A, a human normal breast cell line. Further studies are needed to investigate the potential of applying Guo as a target for the development of a novel cancer treatment system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, 10281 Komuro, Ina-machi, Kitaadachi-gun, Saitama, 362-0806, Japan. Electronic address: y-takizawa@nichiyaku.ac.…
- Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, 10281 Komuro, Ina-machi, Kitaadachi-gun, Saitama, 362-0806, Japan.
Zitieren
APA
Takizawa, Y., Kizawa, M., Niwa, N., Komura, Y., Takahashi, M., Koda, D., Kurita, T., & Nakajima, T. (2023). Specific inhibitory effects of guanosine on breast cancer cell proliferation. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.06.069
Vancouver
Takizawa Y, Kizawa M, Niwa N, Komura Y, Takahashi M, Koda D, et al. Specific inhibitory effects of guanosine on breast cancer cell proliferation. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.06.069
BibTeX
@article{Takizawa2023,
author = {Takizawa, Yusuke and Kizawa, Masayuki and Niwa, Nobuyuki and Komura, Yuya and Takahashi, Masato and Koda, Daiki and Kurita, Takuro and Nakajima, Takanori},
title = {Specific inhibitory effects of guanosine on breast cancer cell proliferation},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.06.069}
}
EUVIMED